PharmiWeb.com - Global Pharma News & Resources
17-Dec-2018

Cell Separation & Characterization in Solid Tumors: Global Markets Through 2023 - ResearchAndMarkets.com

The "Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023" report has been added to ResearchAndMarkets.com's offering.

This report consists of the overall analysis of the market landscape.

It provides in-depth analysis on market size, growth opportunity in market and product types. The report will serve as a source for 360-degree analysis of the market, thoroughly integrating different models.

The report will help the companies and organizations have an all-around analysis of the cell separation and characterization in the solid tumor market and the most preferred markets regionally.

The report includes:

  • An overview of the global markets and technologies for cell separation and characterization in solid tumors
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Overview of the main markers used for isolation, identification and purification for solid tumors, including surface cell-adhesion molecules such as CD133, CD24, hyaluronic acid (HA) receptor CD44, cytoprotective enzymes such as aldehyde dehydrogenase, ALDH, and transcription factors OCT-4, SOX-2
  • Discussion of the various cell separation technique and technologies such as fluorescence-activated cell sorting (FACS), magnet-activated cell sorting (MACS), density gradient centrifugation, dielectrophoretic (DEP), aqueous two-phase system, field flow fractionation (FFF) and microfluidic platforms
  • Coverage of the major products of the industry such as solid tumor kits, multi-marker solid tumor panels, reagents and microchips and micro-beads
  • Comprehensive analysis of the major companies active in the market, including Abbvie, Inc., AstraZeneca, Beckman Coulter, Daiichi Sankyo and Pfizer, Inc.

Companies Profiled

  • AAT Bioquest
  • AbbVie, Inc.
  • Abcodia Ltd.
  • AstraZeneca
  • Astrazeneca
  • Beckman Coulter
  • Bio-Techne Corp.
  • Cayman Chemical
  • Cell Biolabs, Inc.
  • Daiichi Sankyo
  • Eisai Co. Ltd.
  • Epizyme, Inc.
  • Genmab A/S
  • Gilead Sciences, Inc.
  • Glaxosmithkline Plc
  • Illumina, Inc.
  • Janssen
  • Lidds
  • Merck
  • Miltenyi Biotech
  • MP Biomedicals
  • Neogenomics
  • Novocure
  • NSJ Bioreagents
  • Onconova Therapeutics
  • Perkinelmer, Inc.
  • Pfizer Corp.
  • Propanc Biopharma, Inc.
  • R&D Activities
  • Recent Activities
  • Regnix
  • Taiho Pharma
  • Tesaro, Inc.
  • Thermo Fisher Scientific
  • and more...

For more information about this report visit https://www.researchandmarkets.com/research/6fjwhz/cell_separation?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181217005724/en/

Editor Details

Last Updated: 17-Dec-2018